Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001160 · ClinicalTrials.gov registry record
Studies on Tumors of the Thyroid
A clinical trial of Thyroid Cancer and Papillary Thyroid Cancer, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT00001160 is a study of Thyroid Cancer and Papillary Thyroid Cancer that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 2,500 participants, above the 227-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (1001% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001160, a study of Thyroid Cancer and Papillary Thyroid Cancer, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies....
Conditions Studied
Interventions
- DRUG 68-Gallium Dotatate
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1977-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001160
The ClinicalTrials.gov registry entry for NCT00001160 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (1001% higher). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Thyroid Cancer appearing as the primary indexed condition, and to 1 intervention - of which 68-Gallium Dotatate is the first listed.
NCT00001160 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001160 about?
NCT00001160 is a clinical study titled "Studies on Tumors of the Thyroid". Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the contex...
What is the current status of trial NCT00001160?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 1977-06-01.
What conditions does trial NCT00001160 study?
This clinical trial studies the following conditions: Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer.
What interventions are being tested in trial NCT00001160?
The interventions under investigation include: 68-Gallium Dotatate (DRUG).
Who is sponsoring clinical trial NCT00001160?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001160 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
RECRUITING · Phase 2
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RECRUITING
-
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.